During the past decade, Catholic Health Initiatives (CHI) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Catholic Health Initiatives (CHI)" are "Breast Cancer" (1 trials), "HER-2 Positive Breast Cancer" (1 trials) and "Hormone Receptor Positive Breast Cancer" (1 trials). Many other conditions were trialed in "Catholic Health Initiatives (CHI)" in a lesser frequency.

Most popular intervention types in "Catholic Health Initiatives (CHI)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Anastrozole" (1 trials), "Fulvestrant" (1 trials), "Letrozole" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Catholic Health Initiatives (CHI)" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Catholic Health Initiatives (CHI)". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Catholic Health Initiatives (CHI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Catholic Health Initiatives (CHI), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".